Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Water Sci Technol ; 57(5): 687-92, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18401139

RESUMO

Source-separated foodwastes collected from a campus catering facility were processed in bench-scale single-stage anaerobic digesters. The feedstock contained a varied mix of fruits, vegetables, meats and fried foods. A constant organic loading rate (OLR) was maintained with differing hydraulic retention times (HRT). Regular addition of trace elements or prolonged retention time allowed stable digestion at high total volatile fatty acid (TVFA) levels. Reactors on HRT of 25, 50, and 100 days with no micronutrient supplementation exhibited methanogenic failure after approximately 40, 100 and 90 days respectively, while duplicate reactors with micronutrient supplementation maintained stable digestion. An extended HRT of 180 days has so far allowed continued digestion (for reactors with and without micronutrient supplementation) at levels of ammonia nitrogen exceeding 5.7 g l(-1) and volatile fatty acid levels exceeding 15 g l(-1), usually considered inhibitory or toxic.


Assuntos
Micronutrientes/metabolismo , Eliminação de Resíduos/métodos , Amônia/metabolismo , Anaerobiose , Reatores Biológicos , Ácidos Graxos/química , Ácidos Graxos/metabolismo , Ácidos Graxos Voláteis/metabolismo , Humanos , Metano/metabolismo , Fatores de Tempo
4.
Fundam Appl Toxicol ; 40(1): 52-62, 1997 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9398487

RESUMO

Albuterol is a quickly acting beta-2 adrenergic agonist bronchodilator widely used by asthmatics. Because recent case-control studies have suggested a relationship between the increase in mortality of asthmatics over the past decade and the use of beta 2-adrenergic agonists in the control of asthma, concern has developed regarding the potential cardiotoxicity of beta 2-specific adrenergic agonists, including albuterol. The aim of this investigation was to assess the potential for cardiotoxicity of inhaled albuterol dry powder in rats, monkeys, and dogs. All species were exposed to an aerosol of albuterol 1 h per day, 7 days per week, for at least 2 weeks. Control groups were exposed to filtered conditioned air and handled in the same manner as the albuterol-exposed animals. Plasma concentrations of albuterol confirmed systemic exposure. The daily inhaled dose received by the animals was calculated based on measured respiratory minute volumes, published respiratory tract deposition data, as well as HPLC-determined particle size distribution data and aerosolized albuterol concentrations. Multiples of the maximum daily clinical dose (presentation of 15 micrograms/kg in a 70-kg human) were approximately 0.25- to 2500-fold in the rat, 9- to 100-fold in the monkey, and 0.5- to 90-fold in the dog. No findings attributed to albuterol were observed in the monkey. Tachycardia and transient hypokalemia occurred in rats at multiples of 1.5 times or greater of the maximum clinical dose. Absolute and relative heart weights increased in rats receiving multiples of 47 times or greater of the maximum human dose. In the absence of histopathologic findings, the increases in rat heart weights were considered a physiologic hypertrophic response to tachycardia. In dogs tachycardia and transient hypokalemia occurred at all doses tested. Slight to mild fibrosis in the papillary muscles of the left ventricle of the heart occurred in dogs at multiples > or = 19 times the clinical dose. The cardiovascular effects observed were consistent with the known pharmacologic action of beta 2-adrenergic agonists. Due to the lack of toxicologically relevant findings in rats and monkeys and the wide safety margin in dogs, the findings in this study do not suggest a cardiotoxicity risk in the human population after repeated exposures to clinical doses of albuterol currently used in the treatment of asthma.


Assuntos
Agonistas Adrenérgicos beta/toxicidade , Albuterol/toxicidade , Hemodinâmica/efeitos dos fármacos , Administração por Inalação , Agonistas Adrenérgicos beta/administração & dosagem , Agonistas Adrenérgicos beta/farmacocinética , Albuterol/administração & dosagem , Albuterol/farmacocinética , Animais , Cromatografia Líquida de Alta Pressão , Cães , Eletrocardiografia/efeitos dos fármacos , Medidas de Volume Pulmonar , Macaca fascicularis , Miocárdio/patologia , Tamanho do Órgão/efeitos dos fármacos , Tamanho da Partícula , Potássio/sangue , Pós , Ratos , Ratos Sprague-Dawley , Testes de Função Respiratória , Especificidade da Espécie
8.
J Med Chem ; 22(5): 572-5, 1979 May.
Artigo em Inglês | MEDLINE | ID: mdl-458808

RESUMO

A series of molecules of the type GXAsMe2 have been synthesized in which X is S or Se and G is a moiety such as an amino acid, a di- or tripeptide, or a lipid. The compounds have been characterized by NMR, mass spectroscopy, and elemental analysis. Cysteine was found to react directly with dimethylarsinic acid to yield cystine and S-dimethylarsinocysteine (1). This reaction occurs also with other biomolecules containing thiol groups and raises serious questions concerning the use of cacodylate buffers in the study of enzyme kinetics and in sample preparation for electron microscopy. In the presence of dimethylchloroarsine and diethylamine, homocysteine thiolactone reacts to form both the dipeptide and the S-AsMe2 bond. Results of carcinostatic, bacteriostatic, and fungicidal testing of these compounds are reported. A hypothesis is advanced to explain the observed carcinostatic action of the dimethylarsino group.


Assuntos
Aminoácidos/síntese química , Antineoplásicos/síntese química , Arsenicais/síntese química , Esteroides/síntese química , Aminoácidos/farmacologia , Aminoácidos Sulfúricos/síntese química , Aminoácidos Sulfúricos/farmacologia , Animais , Antibacterianos/síntese química , Antifúngicos/síntese química , Arsenicais/farmacologia , Bactérias/efeitos dos fármacos , Leucemia Experimental/tratamento farmacológico , Camundongos , Selênio , Esteroides/farmacologia , Relação Estrutura-Atividade , Enxofre
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA